期刊文献+

血液透析患者血红蛋白变异性和与新发心脑血管事件及动静脉内瘘血栓形成有关 被引量:23

Hemoglobin variation is associated with cardio- cerebro- vascular events and thrombosis in arteriovenous fistula in hemodialysis patients
下载PDF
导出
摘要 目的探讨维持性血液透析患者血红蛋白变异性和新发心脑血管事件及动静脉内瘘血栓形成发生率的关系。方法收集2011年1月在北京大学第三医院肾内科血液透析中心维持性血液透析患者临床及化验资料完整者116例,随访从2011年7月--2013年12月结束。男性62例,女性54例,平均年龄63±13岁,随访记录至2013年12月时上述患者发生心脑血管并发症、动静脉内瘘血栓形成以及全因死亡的终点事件,评估计算每位患者入选前半年血红蛋白的变异性(用患者的血红蛋白变异系数=血红蛋白标准差(SD)/平均数×100%来计算)与心脑血管事件、动静脉内瘘血栓形成以及死亡发生率之间的关系,每位患者计算Charlson合并症评分。结果随访过程中全因死亡19例,心血管死亡9例,26例患者发生心脑血管事件,11例发生动静脉内瘘血栓形成行手术治疗好转,Kaplan-Meier生存曲线分析血红蛋白变异系数大于6.2%及血清白蛋白小于38.1g/L其心脑血管事件及内瘘堵塞的发生率明显增加,Cox回归分析表明血红蛋白变异系数〉6.2%、血清白蛋白〈38.1g/L,Charlson合并症评分是新发心脑血管事件及内瘘堵塞的独立危险因素。结论血液透析患者的血红蛋白变异性和低蛋白血症是新发心脑血管事件、动静脉内瘘血栓形成的独立危险因素。 Objective To investigate the relationship between hemoglobin variation and incidents of cardio- cerebro-vascular events and thrombosis in arteriovenous fistula in maintenance hemodialysis (MHD) patients. Methods A total of 116 MHD patients treated in Peking University Third Hospital in Jan., 2011 were en- rolled in this study, and were followed up from July, 2011 to Dec, 2013 or to the end-point events including cardio-cerebro vascular events, arteriovenous fistula thrombosis, and all-cause mortality. Hemoglobin varia- tion was defined as the coefficient of variation of mean hemoglobin in the six months before follow-up period. We then analyzed the relationship between hemoglobin variation and end-point events. Results Cardio-cere- bro-vascular events, arteriovenous fistula thrombosis, and all-cause mortality occurred in 56 patients during the follow-up period. All-cause mortality happened in 19 patients, cardiovascular mortality in 9 patients, car- dio-cerebro-vascular events in 26 patients, and arteriovenous fistula thrombosis in 11 patients. Kaplan-Meier survival curve analysis indicates that the incidences of cardio-cerebra-vascular events and arteriovenous fistu- la thrombosis increase in patients with higher hemoglobin variation (coefficient of variation of hemoglobin 〉 6.2%) and lower serum albumin (〈38.1g/L). Cox regression analysis shows that coefficient of variation of hemoglobin 〉6.2%, serum albumin 〈38.1g/L and Charlson eomorbidity index are the independent risk factors for cardio-cerebro-vascular events and arteriovenous fistula thrombosis. Conclusions Hemoglobin variation and low serum albumin are associated with cardio-cerebro-vascular events and arteriovenous fistula thrombosis in MHD patients.
出处 《中国血液净化》 2015年第6期337-341,共5页 Chinese Journal of Blood Purification
关键词 血液透析 血红蛋白变异性 心脑血管事件 动静脉内瘘血栓形成 Hemodialysis Hemoglobin variation Cardio-cerebro-vascular event Arteriovenous fistulathrombosis
  • 相关文献

参考文献22

  • 1gesarah A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hemoglobin values in pa- tients with cardiac disease who are receiving hemodial- ysis and epoetin [J]. N Engl J Med, 1998, 339: 584-590.
  • 2Singh AK, Szczech L, Tang EL, et al. Correction of ane- mia with epoetin alfa in chronic kidney disease[J].N EngI J Sed, 2006, 355: 2085-2098.
  • 3Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia[J]. N Engl J Med, 2006, 355: 2071- 2084.
  • 4Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease[J]. N Engl J Sed, 2009, 361:2019-2032.
  • 5Ebben JP, Gilbertson DT, Foley RN, et al. Hemoglobin level variability: associations with comorbidity, in- tercurrent events, and hospitalizations[J]. Clin J Am Soc Nephrol, 2006, 1:1205-1210.
  • 6Yang W, Israni RK, Brunelli SM, et al. Hemoglobin vari- ability and mortality in ESRD[J]. J Am Soe Nephrol, 2007. 18: 3164-3170.
  • 7Di Maseio Rl, Marchioli R, Vitullo F, et al.A positive relation between high hemoglobin values and the risk of ischemie stroke. Progetto 3A Investigators[J]. Eur Neurol,1996,36(2): 85-88.
  • 8樊晓智,李月红,刘宇,肖顺贞,韦洮,于仲元.自体动静脉内瘘阻塞原因分析及护理对策[J].中国血液净化,2004,3(6):319-321. 被引量:82
  • 9Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation[J]..J Chronic Dis, 1987,40(5):373-383.
  • 10Szeto CC, Kwan BC, Chow KM, et al. Haemoglobin vari ability in Chinese pre-dialysis CKD patients not re- ceiving erythropoietin[J]. Nephrol Dial Transplant, 2011, 26: 2919-2124.

二级参考文献112

  • 1李月红,于仲元,王玉柱,朱军,田松.188例尿毒症病人内瘘成熟影响因素分析[J].中国血液净化,2002,1(2):11-14. 被引量:31
  • 2陈雅,倪兆慧.DOPPS研究引发的思考-血红蛋白波动与透析患者死亡正相关[J].中国血液净化,2012,11(4):210-213. 被引量:1
  • 3汤兵.血液透析血管通路的选择和并发症的诊治[J].肾脏病与透析肾移植杂志,1995,4(5):470-472. 被引量:30
  • 4[2]Herhahdez D,Diaz.Subclavian Vascular access stenosis in dialysis patients:Natural history and risk factors.J Am Soc Nephro,1998,1(9):1507-1510
  • 5[6]Ezzahiri R,Lemson MS,Kitalaar PJ.Hacmodialysis vascular access and fistula surveillance methods in the Netherlands.Nephrol Dial Transplant,1999,14(9):2110-2115
  • 6[7]Ori Y,Korzets A,katz M,et al.Hemodialysis arteriovenous access a prospective hemodialysis evaluation .Nephrol Dial Transplant,1996,11[suppl]:94-97
  • 7Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKDMBD). Kidney Int, 2009, 76: S1-S130.
  • 8Slatopolsky E, Moe S. 50 years of research and discovery in chronic kidney disease and mineral & bone disorder: the central role of phosphate. Kidney Int Suppl, 2011, 121: S1- S2.
  • 9Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis, 2008, 52: 519- 530.
  • 10Noordzij M, Korevaar JC, Boeschoten EW, et al. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis, 2005, 46: 925-932.

共引文献120

同被引文献188

引证文献23

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部